APPLICATIONS PUBLISHED 17 DECEMBER 2003

Published: 1-May-2004

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Cholesterol-lowering agents as treatment for psychological and cognitive disorders
    The McLean Hospital Corp 1370210*

  • Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
    Bristol-Myers Squibb 1370211*

  • System and method for intranasal administration of lorazepam
    The University of Kentucky Research Foundation 1370212*

  • Asymmetric benzaldehyde alditol derivatives, methods of making thereof and compsns and articles containing same
    Milliken & Co 1370213*

  • Self-foaming or mousse-type preparations comprising inorganic gel-forming agents and organic hydrocolloids
    Beiersdorf 1370214*

  • Self-foaming or foamed preparations consisting of organic hydrocolloids
    Beiersdorf 1370215*

  • Automatically foaming or foam-type preparations comprising inorganic gel formers
    Beiersdorf 1370216*

  • Method to obtain microparticles containing a H+, K+ -ATP-ase inhibitor
    AstraZeneca 1370242*

  • Novel tablets and capsules and a process for its preparation
    Novo Nordisk 1370244*

  • Method to prepare microparticles that contain metoprolol
    AstraZeneca 1370245*

  • Modulation of release from dry powder formulations
    Advanced Inhalation Research 1370246*

  • Taste masked pharmaceutical compsns
    Ortho-McNeil Pharmaceutical 1370247*

  • Compsns and methods for preventing platelet aggregation
    Philadelphia Health and Education Corp 1370248*

  • Novel dendritic polymers and their biomedical uses
    Duke University 1370249*

  • FLT-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
    Chugai Seiyaku KK 1370250*

  • Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
    Teikoku Pharma 1370251*

  • Thrombopoietin mimetics
    SmithKline Beecham 1370252*

  • Method for protecting cells and tissues from ionising radiation toxicity with a, b unsaturated aryl sulphones
    Temple University of the Commonwealth System of Higher Education; Onconova Therapeutics 1370253*

  • Copper chelators for treating occular inflammation
    The University of British Columbia 1370254*

  • CDC25 phosphatase inhibitors
    Societe de Conseils de Recherches et d'Applications Scientifiques 1370255*

  • You may also like